Programmatic Challenges in Obtaining and Confirming the Pneumococcal Vaccination Status of Cochlear Implant Recipients

Carpenter, Ryan M.; Limb, Charles J.; Francis, Howard W.; Gottschalk, Barbara; Niparko, John K.

doi:10.1097/mao.0b013e3181f395c0

Cited by 13 publications

(13 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Data presented in our study confirm that a sizeable percentage of implanted patients (71.8%) have not been vaccinated against S. pneumoniae , even though it is suggested by government agencies, otolaryngological societies, implant manufacturers, and cochlear implantation centers [ 25 ]. The rate of vaccination in the study group is significantly lower compared to data from USA clinics [ 24 , 25 ]. Although no patients were identified with post-implantation bacterial meningitis in the group, there continued to be new cases of meningitis in the general population.…”

Section: Discussionmentioning

confidence: 61%

See 1 more Smart Citation

Rates of Vaccination against Streptococcus Pneumoniae in Cochlear Implant Patients

Piotrowska

Paradowska-Stankiewicz

Skarżyńśki

2017

Med Sci Monit

View full text Add to dashboard Cite

BackgroundStreptococcus pneumoniae can cause life-threatening illness, with invasive pneumococcal diseases (IPD) like meningitis, sepsis, bacteremic pneumonia, and bacteremia being major causes of morbidity and mortality. Studies have shown that patients who have had a cochlear implant, particularly children, have an increased risk of bacterial (pneumococcal) meningitis. Vaccination in patients with cochlear implants is important and recommended universally. The World Health Organization recommends the use of pneumococcal conjugate vaccines in all countries and considers their use to be a priority in all national immunization programs. The objective of this study was to assess rates of vaccination against Streptococcus pneumoniae in patients with cochlear implants who were implanted at the Institute of Physiology and Pathology of Hearing, Poland.Material/MethodsWe analyzed data from questionnaires administered to 2,628 patients who visited the Implants and Auditory Perception Department (IAPD) of the Institute of Physiology and Pathology of Hearing between January 2014 and March 2016.ResultsThe percentage of vaccinated patients in the study group was 28.2%, most of whom (90.7%) were children. Among the children, 49.3% were vaccinated against S. pneumoniae, but the corresponding rate for adults was only 5.5%.ConclusionsThe percentage of patients with cochlear implants who received vaccination against S. pneumoniae was low, both in children and adults, but especially in adults comparing to available reports.

show abstract

Section: Discussionmentioning

confidence: 61%

“…There are a very limited number of papers reporting on vaccination against S. pneumoniae coverage in cochlear implant patients. Data from USA cochlear implant centers show that vaccination rates range from 49% to 99% [ 24 , 25 ].…”

Section: Introductionmentioning

confidence: 99%

Rates of Vaccination against Streptococcus Pneumoniae in Cochlear Implant Patients

Piotrowska

Paradowska-Stankiewicz

Skarżyńśki

2017

Med Sci Monit

View full text Add to dashboard Cite

show abstract

“…12 However, it is consistent with medically at-risk paediatric pneumococcal vaccine coverage reported at 3-9% nationally, 13 and other international adult and paediatric CI cohorts in Poland (28%) 14 and America (20%). 15 Locally, educational letters and immunisation plans for children scheduled for or who had received CI were effective in improving immunisation rates (Tay SM, unpublished data), suggesting improved parent and provider awareness were key factors influencing optimal infection prevention.…”

Section: Discussionmentioning

confidence: 99%

Infectious complications and optimising infection prevention for children with cochlear implants

Davidson

Foley

Clifford

et al. 2022

J Paediatrics Child Health

View full text Add to dashboard Cite

Aim To describe the clinical epidemiology of children receiving cochlear implants, as well as the management and outcomes of cochlear implant infections and adherence to infection prevention measures. Methods A retrospective observational study was conducted in children ≤18 years who received cochlear implants in Western Australia's tertiary paediatric hospital. Information was obtained from medical and laboratory records regarding demographics, indication for implant, implant infection and preoperative Staphylococcus aureus screening/decolonisation. Immunisation history was examined using the Australian Immunisation Register. Results Overall, 118 children received cochlear implants, with 158 devices inserted (599 cochlear implant insertion‐years). An implant infection rate of 3.8% (6/158) was identified during the study period (four pneumococcal and two community‐acquired methicillin resistant S. aureus infections). All required surgical management, with an overall median duration of antibiotic therapy of 37 days (interquartile range (IQR) 29–48) and median length of stay of 8 days (IQR 8–9.5). All devices were retained and there were no relapses or deaths. Half of the children who developed cochlear implant infections (50%, 3/6) were up‐to‐date with additional pneumococcal vaccinations and no children (0%, 0/118) received S. aureus screening/decolonisation before implant insertion. Conclusions Favourable outcomes were achieved with cochlear implant retention; however, the treatment was burdensome for families. We demonstrate significant scope to improve adherence to existing infection prevention strategies and provide direction for optimising preventative measures in the future. These include ensuring parental education, additional pneumococcal vaccinations and S. aureus decolonisation which are delivered as an infection prevention bundle to the growing population of infants receiving cochlear implants.

show abstract

“…Implementation of the recommendation of a supplemental dose of PCV-13 in patients previously vaccinated with PCV-7 required cochlear implant centers to contact patients and either refer them to primary care for immunization. Complete vaccination was only documented in 49% of adults and 58% of children with prior implants (17). Carpenter and colleagues launched a communication campaign to document vaccination status of their cochlear implant patients.…”

Section: Discussionmentioning

confidence: 99%

“…Few have reported on their attempts to achieve vaccination compliance.The efforts of Carpenter et al (17) published in 2010 are laudable for their successes; nevertheless, the authors stressed it was ''an immense challenge.'' These challenges led the authors to conclude that most patientsVeven after documenting their willingness to complyVwill not reliably obtain vaccinations on their own (17). They noted in 2007 that despite standard notices and verbal recommendations issued at office visits, only 20% to 30% of their cochlear implant patients were immunized at the time of surgery.…”

Section: Discussionmentioning

confidence: 99%

Documenting Immunization of Children in a Cochlear Implant Program

Volsky¹,

Ballard²,

Moody‐Antonio³

2014

Otology &Amp; Neurotology

View full text Add to dashboard Cite

It is a challenge to achieve and document immunizations recommended for cochlear implantation, even in a relatively small cochlear implant program. In our practice, those patients who were required to document immunizations before surgery had the highest rates of compliance. Access to a vaccination registry and the ability to administer vaccines in the otolaryngology office also improved compliance.

show abstract

Programmatic Challenges in Obtaining and Confirming the Pneumococcal Vaccination Status of Cochlear Implant Recipients

Cited by 13 publications

References 5 publications

Rates of Vaccination against Streptococcus Pneumoniae in Cochlear Implant Patients

Rates of Vaccination against Streptococcus Pneumoniae in Cochlear Implant Patients

Infectious complications and optimising infection prevention for children with cochlear implants

Documenting Immunization of Children in a Cochlear Implant Program

Contact Info

Product

Resources

About